National COVID Cancer Antibody Survey

If you live in England and either, have been diagnosed with cancer in the last year, having cancer treatment or have blood cancer, you can enrol to participate in the National COVID Cancer Antibody Survey. The National COVID Cancer Survey is evaluating antibody tests in individuals living with cancer.

The test is a ‘fingerprick’ blood test which checks for coronavirus antibodies. The test kit is posted to you. It comes with everything you need. You take the test and post your sample back. Then you’ll get your results.

The survey will improve understanding of the protection provided by antibodies generated following COVID-19 infection and vaccination in individuals with cancer.

When requesting your kit on, under participant ID, remember to enter “cancersurvey“. You may participate irrespective of the number of COVID vaccines you have received, or whether you are pre- or post- 3rd/booster dose.

Update 11/1/22 – anyone with blood cancer on a watch and wait treatment plan or previously treated for blood cancer with anti-cancer drugs or a stem cell transplant can take part (see FAQs for more details).

Update 26/11- we are delighted that over 1000 people have received their results as part of this survey. The website is operational. If you have had/are having any issues with your 16 digit code or kit order, we recommend you re-request your kit.

Update 27/10- We are delighted to have helped 500 people receive their results as part of this survey.

Update 16/10- We are delighted that 250 people have received their results.

Update 11/10- We are delighted 150 people have received their kit, done their test and received results.

Update 20/09- We are delighted to be able to start welcoming people to participate in the survey. Thanks so much for your support.